SAREPTA THERAPEUTICS INC

CUSIP: 803607AD2 Class: Convertible Debt

SHENKMAN CAPITAL MANAGEMENT INC's Holding History (CIK: 0001275228)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 2,594,000 Value ($000) $2,416 Avg Close — Range —
Q4 2024
Shares 5,173,000 Value ($000) $5,906 Avg Close — Range —
Q3 2024
Shares 1,143,000 Value ($000) $1,299 Avg Close — Range —
Q2 2024
Shares 2,693,000 Value ($000) $3,481 Avg Close — Range —
Q1 2024
Shares 2,693,000 Value ($000) $3,154 Avg Close — Range —
Q4 2023
Shares 3,504,000 Value ($000) $3,576 Avg Close — Range —
Q3 2023
Shares 3,700,000 Value ($000) $4,153 Avg Close — Range —